Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Widman FredrikVP Corporate Controller | ISRGINTUITIVE SURGICAL INC Open-market sale · 10b5-1 plan | SELL | $66K 133 sh | Feb 11, 2026 |
| 13 | Graham-Cumming JohnDirector | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $5,445 32 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 11 | Pitofsky JasonSVP Controller |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $405K 521 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 11 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $304K 391 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 11 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $438K 563 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 9 | Bayview Legacy, LLC10% Owner |  AIPArteris, Inc.Open-market sale · 10b5-1 plan | SELL | $718K 47.2K sh | Feb 11, 2026 traded Feb 9, 2026 |
| 8 | DeHoff KateSee Remarks |  JOBYJoby Aviation, Inc.Open-market sale · 10b5-1 plan | SELL | $161K 16.2K sh | Feb 11, 2026 traded Feb 11, 2026 |
| 4 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $160K 205 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 4 | Rodman David MalcomChief Medical Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $66K 2,171 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 4 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $59K 75 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 4 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $113K 144 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 3 | Bayview Legacy, LLC10% Owner | AIPArteris, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 2,756 sh | Feb 11, 2026 traded Feb 10, 2026 |
| 1 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $20K 26 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 1 | DeHoff KateSee Remarks | JOBYJoby Aviation, Inc. Open-market sale · 10b5-1 plan | SELL | $11K 1,076 sh | Feb 11, 2026 traded Feb 10, 2026 |
| 1 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $29K 37 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 1 | Dutt SubirChief Sales Officer |  XMTRXometry, Inc.Open-market sale · 10b5-1 plan | SELL | $175K 2,500 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 1 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $785 1 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 1 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $42K 53 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 1 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $16K 20 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 59 | Sacks Anelise AngelinoDirector |  RALRalliant CorpOpen-market purchase | BUY | $83K 2,000 sh | Feb 10, 2026 traded Feb 9, 2026 |
| 44 | Gantt Greg CDirector |  ODFLOLD DOMINION FREIGHT LINE, INC.Open-market sale | SELL | $2.36M 12.0K sh | Feb 10, 2026 traded Feb 9, 2026 |
| 43 | Canuso Dominic CEVP & Chief Financial Officer |  TBBKBancorp, Inc.Open-market purchase | BUY | $50K 800 sh | Feb 10, 2026 traded Feb 9, 2026 |
| 43 | Hussain HamidPRESIDENT OF THE BANK |  BANCBANC OF CALIFORNIA, INC.Open-market purchase | BUY | $296K 14.0K sh | Feb 10, 2026 traded Feb 9, 2026 |
| 42 | Canuso Dominic CEVP & Chief Financial Officer | TBBKBancorp, Inc. Open-market purchase | BUY | $121K 2,000 sh | Feb 10, 2026 traded Feb 10, 2026 |
| 39 | Canuso Dominic CEVP & Chief Financial Officer | TBBKBancorp, Inc. Open-market purchase | BUY | $12K 200 sh | Feb 10, 2026 traded Feb 6, 2026 |
| 35 | Mills Desmond JSVP & Chief Accounting Officer |  WFRDWeatherford International plcOpen-market sale | SELL | $541K 5,118 sh | Feb 10, 2026 traded Feb 6, 2026 |
| 31 | Mills Desmond JSVP & Chief Accounting Officer | WFRDWeatherford International plc Open-market sale | SELL | $521K 5,000 sh | Feb 10, 2026 traded Feb 9, 2026 |
| 21 | Wilson John J. AddingtonCHIEF OPERATING OFFICER |  RPIDRAPID MICRO BIOSYSTEMS, INC.Open-market sale | SELL | $17K 4,610 sh | Feb 10, 2026 traded Feb 9, 2026 |
| 12 | Feierstein Matthew DavidPresident |  EVCMEverCommerce Inc.Open-market sale · 10b5-1 plan | SELL | $54K 5,000 sh | Feb 10, 2026 traded Feb 5, 2026 |
| 12 | Smith Brian ScottPresident, Hearth & Home Tech |  HNIHNI CORPOpen-market sale · 10b5-1 plan | SELL | $104K 2,000 sh | Feb 10, 2026 traded Feb 9, 2026 |
| 10 | Smith Chad M.Pres & COO, Better Mortgage |  BETRBetter Home & Finance Holding CoOpen-market sale · 10b5-1 plan | SELL | $58K 2,056 sh | Feb 10, 2026 traded Feb 10, 2026 |
| 8 | Vultaggio VincentPAO and PFO |  ZNTLZentalis Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $73K 30.0K sh | Feb 10, 2026 traded Feb 6, 2026 |
| 8 | Schmitt Thomas NCPO, Skyward Group |  SKWDSkyward Specialty Insurance Group, Inc.Open-market sale · 10b5-1 plan | SELL | $114K 2,616 sh | Feb 10, 2026 traded Feb 9, 2026 |
| 4 | Schwartz LarissaSee Remarks | OKTAOkta, Inc. Open-market sale · 10b5-1 plan | SELL | $153K 1,836 sh | Feb 10, 2026 traded Feb 6, 2026 |
| 1 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $145K 5,000 sh | Feb 10, 2026 traded Feb 6, 2026 |
| 1 | Vultaggio VincentPAO and PFO | ZNTLZentalis Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $17K 6,894 sh | Feb 10, 2026 traded Feb 10, 2026 |
| 1 | Vultaggio VincentPAO and PFO | ZNTLZentalis Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $8,086 3,379 sh | Feb 10, 2026 traded Feb 9, 2026 |
| 59 | Worrell BrianDirector | RALRalliant Corp Open-market purchase | BUY | $100K 2,500 sh | Feb 9, 2026 traded Feb 6, 2026 |
| 55 | Moorthy GaneshDirector | RALRalliant Corp Open-market purchase | BUY | $79K 2,000 sh | Feb 9, 2026 traded Feb 6, 2026 |
| 52 | Bryant Kevin E.Director | RALRalliant Corp Open-market purchase | BUY | $50K 1,250 sh | Feb 9, 2026 traded Feb 6, 2026 |